Alkaline protease

ABSTRACT

An alkaline protease having the following properties; a gene encoding the same; a microorganism producing the same; and washing compositions containing the same; (i) acting over a broad pH value range of 4 to 13 and achieving, at pH 6 to 12, 80% or more the activity at the optimum pH value; (ii) when treated at 40° C. for 30 minutes, being stable over a pH value range of 6 to 11; (iii) having an isoelectric point of about 8.9 to 9.1; and (iv) having casein digesting activity that is not inhibited by oleic acid. The alkaline protease of the present invention is highly stable to various surface active agents and fatty acids, and exhibits high stability to oxidizing agents, and is therefore useful as an enzyme to be used in detergents for automatic dishwashers and laundry detergents, both containing bleaching components.

TECHNICAL FIELD

The present invention relates to an alkaline protease useful as an enzyme incorporated in a detergent; a gene encoding the same; a microorganism producing the same; and a detergent composition containing the same.

BACKGROUND ART

Protease has been widely used in a variety of detergents, such as laundry detergents; cosmetic compositions; bath additives; food-modifying agents; and pharmaceuticals such as digestive aids and antiphlogistics.

Of these, proteases used in detergents are produced in largest amounts on an industrial scale and thus account for a significant part of commercial supply. Examples of such proteases include Alcalase, Savinase (product of Novo Nordisk), Maxacal (product of Genencor), Blap (Product of Henkel), and Protease K (KAP, product of Kao Corporation).

Meanwhile, attempts have been made to improve the performance of enzymes used in detergents. For example, Japanese Patent Application Laid-Open (kokai) No. 6-70765 discloses an enzyme having high stability to heat and a surfactant. Japanese Patent Application Laid-Open (kokai) No. 9-121855 discloses an enzyme which acts on insoluble proteins such as keratin and has a high specific activity. Japanese Patent Application Laid-Open (kokal) Nos. 5-211868 and 9-121856 disclose an enzyme having excellent activity in a low temperature range. European Patent No. 0130756 discloses a method for enhancing stability of an enzyme to an oxidizing agent.

In many cases, soils on laundry comprise a plurality of components such as lipids and solid particles other than protein. Therefore, there is demand for a detergent having excellent detergency to such complex soils. In order to meet the demand, generally a plurality of enzymes and surfactants have been incorporated into a detergent.

However, even though a plurality of enzymes are incorporated, their effects cannot be fully exerted if, in the presence of complex soils, the enzymes are unstable and do not exhibit constant and sufficient activity. Conventional enzymes are unsatisfactory in this point.

DISCLOSURE OF THE INVENTION

In view of the foregoing, the present inventors have discovered an alkaline protease which has a constant casein-degrading activity even in the presence of a fatty acid at a high concentration and exhibits excellent detergency even under complex soil conditions; e.g., soils containing protein and sebum.

Accordingly, in one aspect of the present invention, there is provided an alkaline protease which has the following physicochemical properties:

(i) Acting pH range

acting over a wide pH range of 4-13 and exhibiting, at a pH of 6-12, 80% or more the activity at the optimum pH;

(ii) Stable pH range

being stable over a pH range of 6-11 when treated at 40° C. for 30 minutes;

(iii) Isoelectric point

having an isoelectric point of approximately 8.9-9.1; and

(iv) Effect of a fatty acid

casein-degrading activity not being inhibited by oleic acid.

In another aspect of the present invention, there is provided a gene encoding the above-described alkaline protease.

In still another aspect of the present invention, there is provided a microorganism producing the above-described alkaline protease.

In yet another aspect of the present invention, there is provided a detergent composition containing the above-described alkaline protease.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows the the effects of pH on the activity of alkaline protease KP43. FIG. 2 shows the effects of pH on the stability of alkaline protease KP43 (40° C., 30 minutes). FIG. 3 shows the effects of pH on the stability of alkaline protease KP43 (10° C., 24 hours). FIG. 4 shows the effects of temperature on the activity of alkaline protease KP43. FIG. 5 shows the effects of temperature on the stability of alkaline protease KP43. FIG. 6 shows the effect of an oxidizing agent (50 mM hydrogen peroxide) on the activity of alkaline protease KP 43. FIG. 7 shows N-terminal sequences of KP9860 protease and partially degraded products thereof SEQ ID NOS:9-13. FIG. 8 shows primer sequences SEQ ID NOS:14-20 designed from an N-terminal sequence of KP9860 protease SEQ ID NOS:9-13. FIG. 9 shows 57 bp PCR-amplified fragments and primer designs SEQ ID NOS:21-24.

BEST MODE FOR CARRYING OUT THE INVENTION

The alkaline protease of the present invention has the above-described physicochemical properties (i) through (iv). Of these, property (iv) is particularly important. The alkaline protease has a casein-degrading activity in the presence of 10 mM of oleic acid, a component of sebum, as high as that in the absence of oleic acid.

The alkaline protease of the present invention preferably has (v) an estimated molecular weight of approximately 43,000 as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).

Particularly preferred is an alkaline protease having, in addition to properties (i) through (v), properties (vi) through (ix) as described below.

(vi) Acting temperature and optimum temperature acting at an optimum temperature of 60° C.-70° C., and also acting at a temperature as low as 20° C. or lower;

(vii) Effects of metal ions

activity being inhibited by Hg²⁺ and Cu²⁺ and thermal stability being enhanced by Ca²⁺;

(viii) Effects of inhibitors

activity not being inhibited by ethylenediaminetetraacetic acid (EDTA) and p-chloromercurybenzoic acid (PCMB) and activity being inhibited by diisoproyl fluorophosphate (DFP) and phenylmethanesulfonyl fluoride (PMSF); and

(ix) Effects of surface active agents

activity not being inhibited by linear sodium alkylbenzenesulfonate, sodium polyoxyethylene alkyl sulfate, sodium dodecyl sulfate, sodium α-olefinsulfonate, or α-sulfofatty acid ester.

The alkaline protease of the present invention preferably has an amino acid sequence shown SEQ ID NOS:1 or 2, or such a sequence in which one or more amino acids are deleted, substituted, or added. SEQ ID NOS:1 differs from SEQ ID NOS:2 in that lysine at the 3rd position in SEQ ID NOS:2 is deleted. Xaa in. SEQ ID NOS:1 and 2 refers to an arbitrary amino acid. Preferable amino acids for Xaa at each position in SEQ ID NOS:2 are shown in the following Table.

TABLE position Position 24 Ser or Asn 30 Gly or Asp 33 Asn or Thr 47 Ala or Val 48 Lys or Ser 54 Gly or Arg 71 Pro or Leu 75 Gln or Leu 90 Ile or Val 103 Gln or Lys 106 Lys or Thr 129 Lys or Gln 131 Ala or Lys 132 Thr or Val 133 Ser or Arg 134 Thr or Ser 147 Ile or Lys 149 Arg or Lys 161 Glu or Thr 166 Val or Leu 173 Lys or Asn 184 Gln or Glu 188 Phe or Tyr 189 Ala or Val 190 Ile or Ala 195 Leu or His 287 Ser or Ala 307 Gly or Ser 325 Tyr or Phe 370 Gly or Arg 432 Phe or Tyr 502 Ile or Val 532 Ser or Ala 542 Ser or Thr 585 Gln or Arg 592 Thr or Ser 593 Ser or Ala 595 Tyr or Phe 596 Asn or Asp 597 Asp or Asn 612 Ala or Ser 633 Thr or Asn

Deletions, substitutions, substitutions, and additions in the alkaline protease of the present invention are not particularly limited. However, the amino acid sequence shown in Sequence No. 1 or 2 is preferably conserved in the amount of 70% or more, preferably 80% or more, particularly preferably 90% or more.

Examples of the alkaline proteases include alkaline proteases having an amino acid sequence shown by SEQ ID NOS:4, 6, or 8 or such a sequence in which one or more amino acids are deleted, substituted, or added.

The alkaline protease of the present invention may be produced by cultivating alkaline protease-producing microorganisms belonging to the genus Bacillus and collecting the enzyme from the culture broth. Examples of alkaline protease-producing microorganisms according to the present invention include wild strains belonging to the genus Bacillus and a transformant containing a gene encoding a peptide having the above-described amino acid sequence. Examples of the wild strains include KP-43, KP-1790, and KP-9860. Mycological characteristics of these strains are shown below.

TABLE 1-a KP43 KP1790 KP9860 A. Morphological characteristics (a) Gram's staining positive positive positive (b) Aminopeptidase undefined undefined undefined (c) Movement yes yes yes (d) Flagella peritrichous peritrichous peritrichous flagella flagella flagella (e) Spores (type, shape, sporogenous, sporogenous, sporogenous, site, swell) eliptical, eliptical, eliptical, central, central, central to none none terminal, swollen B. Physiological characteristics (a) Nitrate reduction negative negative negative (b) Production of indole negative negative negative (c) Growth pH range can grow at can grow at can grow at pH 6.2-11.7, pH 6.2-11.7, pH 6.2-10.0, well grow at well grow at well grow at pH 8-10 pH 8.5-10 pH about 9 (d) Resistance to cannot grow cannot grow cannot grow sodium chloride under ≧7% under ≧7% under ≧7% NaCl NaCl NaCl (e) Growth temperature 10-40° C. 10-40° C. 20-40° C. range (f) β-Galactosidase positive positive positive (g) Arginine dihydrolase negative negative negative (h) Lysine dihydrolase negative negative negative (i) Oxydase positive positive positive (j) Utilization of negative negative negative citric acid (k) Utilization of urea negative negative negative (l) Catalase positive positive positive (m) Gas production from negative negative negative glucose and nitrate (n) Growth under negative negative negative anaerobic conditions (o) V-P test negative negative negative (p)Acid production from sugar D-Glucose + ± + L-Arabinose − − − D-Xylose − − − D-Mannitol + + + D-Galactose ± − − Sucrose + + + D-Mannose + ± + Inositol − − − D-Sorbitol + − − Trehalose ± + + Lactose − − − Glycerol − − − Maltose + ± + D-Fructose + + + Raffinose − − − Melibiose + − − Starch + + +

Based on the above-described mycological characteristics, the three strains were examined by reference to the pertinent descriptions in “Bergey's Manual of Systematic Bacteriology” (Williams & Wilkins Co., 1984), and were considered to belong to the genus Bacillus. However, these strains are novel microorganisms in that characteristics of these species do not completely match those of known species belonging to the genus Bacillus. Thus, the three strains were deposited with National Institute of Bioscience and Human Technology, Agency of Industrial Science and Technology (1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki, 305-0046, JAPAN) as Bacillus sp. KSM-KP43 (FERM BP-6532), Bacillus sp. KSM-KPI790 (FERM BP-6533), and Bacillus sp. KSM-KP9860 (FERM BP-6534) (Date of original deposit: Sep. 18, 1996).

In order to produce the alkaline protease of the present invention by use of the above-described strains, the strains are inoculated in a medium containing an assimilablecarbon source, a nitrogen source, and essential nutrients and are cultured through a customary method.

Collection and purification of a target alkaline protease from the thus-obtained culture broth can be performed according to conventional methods applicable to the collection and purification of common enzymes. For example, cells are separated from the culture broth by centrifugation or filtration, and the target alkaline protease can be obtained from the supernatant through a customary purification method. The thus-obtained enzyme liquid may be used as such or may be further purified and crystallized through a known method.

Alternatively, the alkaline protease of the present invention may be produced through the following steps: obtaining a gene encoding the alkaline protease; preparing a recombinant vector by use of the gene; transforming a host cell by use of the recombinant vector; cultivating the obtained transformant; and collecting the target alkaline protease from the cultured product.

The gene encoding the alkaline protease of the present invention may be cloned from any of the three above-described strains. Cloning may be performed through known methods. Examples of the methods include (1) the shot gun method comprising preparation of a DNA fragment through complete or partial digestion of chromosomal DNA by use of an appropriate restriction endonuclease; combination of the fragment into a suitable vector; and expression through introduction to Escherichia coli or Bacillus subtilis, and (2) a method comprising synthesis of an appropriate primer and cloning a target gene through PCR.

Examples of the nucleotide sequence of the alkaline protease of the present invention are shown in SEQ ID NOS:3, 5, or 7. The nucleotide sequence is not limited to SEQ ID NOS:3, 5, and 7 and acceptable sequences may include a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO:1 or 2, and a nucleotide sequence encoding such an amino acid sequence in which one or more amino acids are deleted, substituted, or added. Of these, nucleotide sequences represented by SEQ ID NOS:3, 5, and 7 or such sequences in which one or more amino acids are deleted, substituted, or added are preferred. In these cases, deletion, substitution, or addition preferably occurs within the above-described variation of amino acid sequence.

In order to prepare a recombinant vector including the above-described gene encoding an alkaline protease, the gene may be incorporated into an arbitrary vector suitable for expression of the gene in a host of interest. Examples of the vectors include pUC18, pBR322, and pUC19 in the case in which Escherichia coli serves as a host and pUB110 in the case in which Bacillus subtilis serves as a host.

A host is transformed by use of the thus-obtained recombinant vector through a customary method such as the protoplast method or the competent cell method. Although no particular limitation is imposed on the host, microorganisms are preferred. Examples include Gram-positive bacteria such as microorganisms belonging to the genus Bacillus, Gram-negative bacteria such as Escherichia coil, yeast belonging to Saccharomyces, and fungus belonging to Aspergillus.

In order to produce the alkaline protease of the present invention through culturing of the obtained transformant, cultivation, collection, and purification may be performed in accordance with a procedure employed in the case in which the above-described wild strain is used.

As described above, the alkaline protease of the present invention has excellent resistance to alkaline conditions and excellent protease activity even in the presence of lipids. Thus, the alkaline protease is useful for an enzyme incorporated in a variety of detergent compositions.

No particular limitation is imposed on the amount of the above-described alkaline protease incorporated into a detergent composition, and the amount is preferably 0.1-5000 U based on 1 kg, particularly preferably 1-500 U, of the detergent composition.

Known detergent components may be incorporated into the detergent composition of the present invention containing the alkaline protease. For example, components described in WO94/26881 (p. 5, upper-right column, line 14—lower-right column, line 29) may be employed.

A surfactant is incorporated into the detergent composition in an amount of 0.5-60 wt. % (hereinafter simply referred to as “%”), particularly preferably 10-45%, into a powdery detergent composition and in an amount of 20-50% into a liquid detergent composition. When the detergent composition of the present invention serves as a bleaching detergent composition or a detergent composition for an automated dishwasher, a surfactant is typically incorporated in an amount of 1-10%, preferably 1-5%.

A divalent metal ion scavenger is incorporated in an amount of 0.01-50%, preferably 5-40%.

An alkali agent and an inorganic salt are incorporated in an amount of 0.01-80%, preferably 1-40%.

An anti-redeposition agent is incorporated in an amount of 0.001-10%, preferably 1-5%.

The detergent composition may contain an enzyme other than the alkaline protease of the present invention. Examples include cellulase, amylase, protopectinase, pectinase, lipase, hemicellulase, β-glucosidase, glucose-oxidase, and cholesterol-oxidase. These enzymes are incorporated in an amount of 0.001-5%, preferably 0.1-3%.

A bleaching agent such as hydrogen peroxide or percarbonate is preferably incorporated in an amount of 1-10%. When a bleaching agent is incorporated, a bleach-activator may be incorporated in an amount of 0.01-10%.

Examples of fluorescent agents incorporated into the composition include a biphenyl compound, such as Cinopearl CBS-X, and a stilbene compound such as DM-type fluorescent agent. The fluorescent agent is preferably incorporated in an amount of 0.001-2%.

The above-described detergent composition may be processed into a variety of forms such as liquid, powder, and granules. The detergent composition may be used for laundry, an automated dishwasher, drain pipes, and dentures, and may be used as a bleaching agent.

EXAMPLES Example 1 Screening for Alkaline Protease-producing Microorganisms

A soil sample (1 g) was suspended in physiological saline (10 ml) and thermally treated at 80° C. for 10 minutes, followed by inoculation in liquid enrichment medium for protease-producing microorganisms, the medium having the following composition, to thereby culture at 20° C. After subculture enrichment was repeated about three times in the same medium, the cultivated product was smeared onto a plate for judging protease-production and cultivated at 20° C. for 5-7 days. Colonies around which a transparent zone was formed by dissociation of skim milk were selected for collection of protease-producing microorganisms. By means of the above procedure, the Bacillus sp KSM-KP43 strain, the KSM-KP1790 strain, and the KSM-KP9860 strain were obtained as alkaline protease-producing microorganisms.

TABLE 2 Composition of liquid enrichment medium for screening (pH 11) Monopotassium phosphate 0.1% Magnesium sulfate  0.02% Yeast extract (Difco)  0.05% Keratin (Tokyo Kasei) 1.0% Glucose 0.5% Sodium carbonate 0.3% Agar plate medium for screening Nutrient agar (Difco) 2.3% Skim milk (Difco) 0.3% Sodium carbonate 1.0%

Example 2

The Bacillus sp KSM-KP43 strain obtained in Example 1 was inoculated in a liquid medium comprising polypeptone S (1%), yeast extract (0.05%), potassium phosphate (0.1%), magnesium sulfate (0.02%), glucose (separately sterilized) (1%), and sodium carbonate (separately sterilized) (0.5%) to thereby be cultivated at 30° C. for 24 hours. The concentration of enzyme in the supernatant liquid was about 1.5 U/L. The supernatant liquid which had been centrifugally separated from cells at 4° C. was added with pulverized ammonium sulfate under stirring so as to attain 90% of saturated concentration. The solution was maintained under stirring at 4° C. for an entire day and night and the resultant precipitate was centrifugally collected. The obtained precipitate was dissolved in 10 mM of a Tris-hydrochloric acid buffer solution (pH 7.5)-containing 5 mM of calcium chloride, followed by dialysis through the buffer solution. Subsequently, the dialyzed liquid was applied to a DEAE-Sepharose FF column (product of Pharmacia) which had been equilibrated with 10 mM of a Tris-hydrochloric acid buffer solution (pH 7.5) containing 5 mM of calcium chloride, to thereby collect the non-absorbed fraction. The fractionated liquid was dialyzed through 50 mM of HEPES buffer solution (pH 7.5) containing 2 mM of calcium chloride and was applied to a SP-Sepharose FF column which had been equilibrated with the same buffer solution, to thereby collect an active fraction which has eluted slightly after the non-absorbed fraction. While the active fraction, which had a recovery ratio of 15%, was used as a sample, SDS-polyacrylamide electrophresis was carried out, and as a result, a single band was obtained for the respective enzyme.

Example 3

The obtained Bacillus sp KSM-KP1790 strain and KSM-KP9860 strain were cultivated in the same medium as in Example 2 and the alkaline protease was purified in the same manner as in Example 2.

Example 4

Enzymatic properties of the alkaline proteases obtained in Example 2 and 3 were examined. The methods and results of the experiments are described below.

I. MATERIALS AND METHODS FOR EXPERIMENTS

(1) Methods for Activity Measurement

(a) Method in Which Casein is Used as a Substrate

After 1 mL of 50 mmol/L of various buffer solutions containing 1% (w/v) Casein (Hammerstein: product of Merck Inc.) was maintained at 40° C. for 5 minutes, 0.1 mL of an enzyme solution was added to the solution, followed by incubation at 40° C. for 10 minutes. 2 mL of a TCA solution (0.11 mol/L trichloroacetic acid:0.22 mol/L sodium acetate:0.33 mol/L acetic acid) was added to stop the reaction and the mixture was left to stand at room temperature for 10 minutes. Subsequently, acid-denatured protein was filtered (No. 2 filter paper: product of Whattmann). To 0.5 mL of the filtrate, 2.5 mL of alkaline copper reagent (1% (w/v) sodium potassium tartrate:1% (w/v) copper sulfate:2% (w/v) sodium carbonate, 0.1 mol/L sodium hydroxide=1:1:100 (v/v)) was added, and after the solution was maintained at 30° C. for 10 minutes, 0.25 mL of diluted phenol reagent (phenol reagent (product of Kanto Chemical) diluted two-fold with deionized water) was added, and after being maintained at 30° C. for 30 minutes, the solution was subjected to an absorbance measurement at 660 nm. The following solution was used as a blank: to the above-described system of enzyme reaction, a reaction termination solution was mixed and then the enzyme solution was added.

One unit (P.U) of enzymatic activity was defined as the amount of enzyme that released acid-soluble protein degradation products equivalent to 1 mmol of tyrosine per minute under the above reaction conditions.

(b) Method in Which Synthetic Oligo-peptide is Used as a Substrate

0.05 mL of 50 mmol/L synthetic oligo-peptide solution (succinyl-alanyl-alanyl-prolyl-leucine para-nitroanilide dissolved in dimethyl sulfoxide) was mixed into 0.9 mL of 100 mmol/L boric acid buffer solution (pH 10.0, containing 2 mmol/L of calcium chloride), and after the solution was maintained at 30° C. for 5 minutes, 0.05 mL of an enzyme isolution was added, followed by incubation at 30° C. for 10 minutes. 2 ml of 5% (w/v) citric acid was added to stop the reaction and absorbance at 420 nm was measured.

One unit (U) of enzymatic activity was defined as the amount of enzyme that released acid-soluble protein degradation products equivalent to 1 mmol of tyrosine per minute under the above reaction conditions.

(c) Method in Which Hemoglobin is Used as a Substrate

According to the method by Anson (M. L. Anson, J. Gen. Physiol. 22, 79(1983)), hemoglobin of bovine blood serum was denatured by use of urea and adjusted to pH 10.5 with sodium hydroxide. 0.1 mL of an enzyme solution (1.0×10⁻⁵-1.0×10⁻³ A.U) was added to 0.5 mL of the substrate solution (2.2% in terms of hemoglobin), and the resultant solution was incubated at 25° C. for 10 minutes. To the resultant solution, 1.0 mL of 4.9% tirchloroacetic acid was added to stop the reaction. After completion of the reaction, centrifugation (3,000 rpm, 10 minutes) was carried out and protein degradation products in the supernatant liquid were quantitatively determined according to the Folin-Lowry method (O. H. Lowry et al., J. Biol. Chem., 19, 265(1951)).

One unit (A. U) of enzymatic activity was defined as the amount of enzyme that released acid-soluble protein degradation products equivalent to 1 mmol of tyrosine per minute under the above reaction conditions.

(2) Optimum pH

0.1 mL of an enzyme solution (3.0×10⁻⁵ mP. U) was added to 1 mL of 50 mmol/L Britton-Robinson buffer solution containing 1% (w/v) casein, and activity was measured according to the casein method.

(3) pH Stability

An enzyme solution (8.0×10⁻⁴ mP. U.) was mixed into Britton-Robinson buffer solution (20 mmol/L, containing 2 mmol/L calcium chloride), followed by treatment at 40° C. for 30 minutes or at 10° C. for 24 hours. After ice-cooling, the treated solution was diluted 40-fold with 50 mmol/L boric acid buffer solution, followed by measurement of residual activity according to the method in which casein is used as a substrate.

(4) Optimum Temperature

0.1 mL of the enzyme solution (2.0×10⁻⁵ mP. U.) was added to 1 mL of 50 mmol/L boric acid buffer solution (pH 10.0) containing 1% (w/v) casein, and activity of the enzyme was measured at temperatures between 10-80° C. according to the casein method.

The activity measurements were conducted in both systems; i.e., in the presence of and in the absence of 5 mmol/L calcium chloride.

(5) Heat Stability

An enzyme solution (2.5×10⁻⁴ mP. U.) was added to 20 mmol/L boric acid buffer solution (pH 10.0) in both systems; i.e.,. in the presence of and in the absence of 5 mmol/L calcium chloride, and thermally treated at the appropriate temperature for 10 minutes. After being cooled with ice, the treated solution was diluted 5-fold with 50 mmol/L boric acid buffer solution (pH 10.0), and residual activity was measured using casein as a substrate.

(6) Effects of Metal Ions

An enzyme solution (4.0×10⁻⁴ mP. U.) was added to 20 mmol/L boric acid buffer solution (pH 10.0) containing 1 mmol/L various metal salts, and the resultant solution was incubated at 30° C. for 20 minutes. The solution was diluted 5-fold with 50 mmol/L boric acid buffer solution (pH 10.0), followed by measurement of activity using casein as a substrate.

(7) Effects of Inhibitors

The enzyme solution (1.0×10⁻³ mP. U.) was added to 10 mmol/L phosphoric acid buffer solution (pH 7.0) containing various inhibitors so as to attain a predetermined concentration, and the solution was incubated at 30° C. for 20 minutes. Subsequently, the solution was diluted 20-fold with deionized water, and residual activity was measured using casein as a substrate.

(8) Effects of Surfactants

An enzyme solution (7.0×10⁻⁴ mP. U.) was added to 100 mmol/L boric acid buffer solution containing dissolved surfactants in an amount of 1%, and the resultant solution was incubated at 40° C. for 4 hours. The solution was diluted 20-fold with 50 mmol/L boric acid buffer solution (pH 10.0), and residual activity was measured using casein as a substrate.

(9) Effects of Oxidizing Agent (hydrogen peroxide)

2.7 mL of Britton-Robinson buffer solution containing hydrogen peroxide and calcium chloride (final concentration: 50 mmol/L hydrogen peroxide, 2 mmol/L calcium chloride, 20 mmol/L Britton-Robinson) (pH 8.0) was maintained at 30° C. for 15 minutes, and then 0.3 mL of an enzyme solution was added. With the passage of time, 0.8 mL of the resultant solution was sampled in a previously prepared test tube containing 5 μL of catalase (Boehringer Mannheim Co.: 20 mg/L), to thereby stop the oxidation reaction. Each sample was suitably diluted with 2 mmol/L calcium chloride, and residual activity was measured according to the method in which synthetic oligo-peptide is used as a substrate.

(10) Effects of Fatty Acids

By use of 50 mM phosphoric acid buffer solution (pH 7) containing 1% (w/v) casein as a substrate solution, a reaction was carried out in the presence of 0-10 mM sodium oleate at 20° C. for 15 minutes, and activity was measured using casein as a substrate.

II. Results

(1) Optimum pH

Effects of pH on three kinds of protease (KP43, KP1790, and KP9860) were examined. FIG. 1 shows the activities of KP43 at each pH value normalized with respect to activity at optimum pH (100%), indicating that the optimum working pH range of the proteases of the present invention is 6-12. Thus, these enzymes exhibit a high protein-degradation activity in the extensively broad working pH range.

(2) pH Stability

After being allowed to stand at 40° C. for 30 minutes or at 10° C. for 24 hours, the residual activity of KP43 was measured over a range of pH values. FIGS. 2 and 3 show the residual activities normalized with respect to the enzyme activity before treatment (100%). The results show that the enzymes of the present invention are stable over the pH range of 6-12 after treatment at 40° C. for 30 minutes, and that addition of calcium ions improves enzyme stability at pH 5. Similarly, the results show the enzymes of the present invention are stable over the broad pH range of 5-12 after treatment at 10° C. for 24 hours.

(3) Optimum Temperature

By use of casein as a substrate, the effects of temperature on the proteases were examined. FIG. 4 shows the activities of KP43 over a range of temperatures, normalized with respect to the highest activity in the absence of calcium ions (100%). The results indicate that in the absence of calcium ions the optimum temperature is 60° C., and in the presence of calcium ions the optimum temperature is 70° C. for all three kinds of proteases. Therefore, the results show that the optimum temperature is shifted upward by addition of calcium ions, as is the case with conventional proteases for a detergent.

(4) Heat Stability

Heat treatment was carried out for 10 minutes at temperatures in the range of 30-80° C. (pH 10.0, in the presence of and in the absence of 5 mmol/L calcium chloride), a and residual activity was measured. FIG. 5 shows residual activity of KP43 at each treatment temperature, normalized with respect to the activity before treatment (100%). The results indicate that the proteases are stable at the temperature up to 60° C. in the absence of calcium chloride, and that addition of calcium chloride (5 mmol/L) has the effect of shifting temperature stability upward about 10° C. In comparison with commercially available detergent enzymes, these enzymes have high temperature stability; namely, stability comparable to that of Esperase, which exhibits the most excellent temperature stability among commercially available enzymes.

(5) Effects of Metal Ions

In 20 mmol/L boric acid buffer solution (pH 10), 3 kinds of proteases were treated with various metal salts (1 mmol/L) at 30° C. for 20 minutes and the residual activity was measured. Residual activity is normalized with respect to enzyme activity obtained for protease treated in the same manner except without the addition of metal salts (100%) (see Table 3.) The results show that the activity is inhibited by mercury chloride and silver nitrate but that the activity is extremely stable for other metal salts.

TABLE 3 Metal salt Residual activity (%) (1 mM) KP43 KP1790 KP9860 not added 100  100 100 AgNO₃ 66 70 45 NiCl₂ 92 95 96 CaCl₂ 97 95 101 CoCl₂ 91 101 98 FeCl₃ 93 113 96 ZnCl₂ 85 94 91 CuCl₂ 91 96 94 HgCl₂ 38 37 33 MgCl₂ 92 103 100

Treatment conditions: 1 mM metal salt, 20 mM borate buffer (pH 10.0) 30° C., 20 minutes

(6) Effects of Various Inhibitors

Effects of general enzyme inhibitors on the alkaline proteases of the present invention were examined. A variety of inhibitors were added to 10 mmol/L phosphoric acid buffer solution (pH 7.0) so as to attain the predetermined concentration, and the resultant solution was incubated at 30° C. for 20 minutes, after which residual activity was measured. The residual activity is normalized with respect to the enzyme activity obtained for protease treated in the same manner as described above in the absence of inhibitors (100%) (refer to Table 4). The results indicate that for all three kinds of proteases activity was inhibited by diisopropyl fluorophosphoric acid (DFP), phenylmethanesulfonyl fluoride (PMSF), and chymostatin, which are known inhibitors of serine protease. Therefore, the proteases of the present invention are considered to have serine residue in its active center. In contrast, effects of actinomycetes-derived antipine and leupeptin, which has been reported to inhibit serine protease, were not found.

TABLE 4 Residual activity (%) Concentra- Inhibitor tion (mM) KP43 KP1790 KP9860 free — 100 100 100 EDTA 5 110 97 101 EGTA 5 92 91 90 o-Phenanthroline 5 100 103 100 DTT 5 104 102 105 PCMB 1 125 115 126 NEM 5 97 100 100 DFP 1 14 17 16 PMSF 1 0 0 0 Chymostatin 0.1 87 87 80 Antipine 0.1 103 99 97 Leupeptin 0.1 102 101 93 E-64 0.1 104 99 103 Elastatinal 0.1 99 102 102 EDTA: ethylenediaminetetraacetic acid (Sigma) EGTA: ethyleneglycoltetraacetic acid (Sigma) DTT: dithiothreitol (Sigma) PCMB: p-chloromercury benzoate (Sigma) NEM: N-ethylmaleimide (Sigma) DFP: diisopropylfluorophosphoric acid (Sigma) PMSF: phenylmethanesulfonyl fluoride (Sigma)

(7) Effects of Surface Active Agents

Each protease was treated with a variety of 1% surface active agent at 40° C. for 4 hours in 0.1 mol/L Tris-hydrochloride buffer solution (pH 9.0), and residual activity was measured. Residual activity is normalized with respect to the enzyme activity in the case of no treatment (100%) (refer to Table 5.), indicating that the three kinds of enzymes are extremely stable to surfactants typified by linear alkylbenzenesulfonic acid (LAS). Accordingly, the enzymes are considered to be useful as a detergent component containing surfactants.

TABLE 5 Surfactant Residual activity (concentration: 1%) KP43 KP1790 KP9860 free 100 100 100 Na linear 100  88 100 alkylbenzenesulfonate (LAS) Na polyoxyethylene 101 102 104 alkylsulfate (ES) Na dodecyl sulfate (SDS) 104  97 103 Na α-olefinsulfonate (AOS) 100 111 100 Na alkyl sulfate (AS) 113 107 107 α-Sulfofatty acid ester (α- 112 113 105 SFE) Softanol 70H 109 109 104

Treatment conditions: 1% surfactant, 100 mM borate buffer (pH 10.0) 40° C., 4 hours

(8) Effects of Oxidizing Agents

Each protease was treated at 30° C. in 50 mmol/L Britton-Robinson buffer solution containing hydrogen peroxide (pH 8.0), and the residual activity was measured with passage of time. As shown in FIG. 6, KP43 exhibited much greater stability than that of commercially available Savinase or KAP and showed stability as high as that of Durazyme (Novo Nordisk), which was developed by imparting oxidizing agents-resistance to Savinase by use of protein engineering techniques.

(9) Effects of Fatty Acids

As shown in Table 6, the activity of alkaline proteases of the present invention was not inhibited by oleic acid, one of the components of sebum.

TABLE 6 Relative activity (%) in the presence of fatty acid oleic acid concentration (mM) 0 1 2 5 10 KP43 protease 100 100 100 103 119 KP1790 protease 100 100 100 103 121 KP9860 protease 100 100 100 100 106

Example 5 Cloning of a Gene Encoding KP9860 Protease

(1) Preparation of genomic DNA of KSM-KP9860

The KSM-KP9860 strain was cultivated in a liquid medium (0.5% glucose, 0.2% Polypepton-S, 0.05% yeast extract, 0.1% KH₂PO₄.7H₂O, 0.26% NaCO₃: pH 9.0) (500 mL) at 30° C. for two days, and the cells were collected by centrifugation. Genomic DNA was prepared from the obtained cells by the method of Saito and Miura (Biochim. Biophys. Act, 72, 619(1963)).

(2) Limited Proteolysis of KP9860 Protease

1) Denaturation of KP9860 protease KP9860 protease (5 mg/mL) 45 μL PMSF (100 mM) 20 μL EDTA (200 mM) 10 μL SDS (0.08 mg/mL) 25 μL

A protease solution with the above composition was heated in boiling water for 10 minutes. The protease solution was dialyzed against ammonium acetate (2 mM), to thereby remove SDS, EDTA, and PMSF, and was then lyophilized. Subsequently, the lyophilized protease was dissolved in distilled water (100 μL), to thereby serve as a sample of denatured protein.

2) Limited proteolysis by trypsin Denatured protein sample 100 μL Trypsin (1 μg/mL, Sigma) 100 μL 1M Tris-HCl (pH 7.5)  50 μL Distilled water 750 μL

Trypsin was allowed to react against the deratured protein prepared in 1) in an ice bath for 3 hours in the solution with the above composition. After addition of 300 μL of SDS (0.08 mg/mL), 100 μL of EDTA (200 mM) and 200 μL of PMSF (100 mM), limited proteolysis was terminated by heating in boiling water for 3 minutes.

SDS, EDTA, and PMSF were removed through dialysis against ammonium acetate (2 mM), and the solution was lyophilized. Subsequently, the lyophilized was dissolved in distilled water (100 μL), to thereby serve as a sample for SDS-PAGE.

3) Recovering of the Partially Degraded Product

The sample obtained in 2) was subjected to SDS-PAGE with 12% Ready-gel-J (product of Bio-Rad). Protein bands were detected through staining with quick CBB staining solution (product of Bio-Rad). The gel containing the protein band was cut with a razor, and the gel slice was crushed into pieces in a 1.5-mL tube. The buffer for SDS-PAGE (composition: glycine 14.4% (W/V), Tris 3.03%, SDS (product of Bio-Rad) 10%) was added in 5 volumes of the crushed gel, and the mixture was stirred at room temperature, to thereby elute the protein band. The eluate was dialyzed against ammonium acetate (2 mM) and was then lyophilized. The lyophilized sample was served to determine the N-terminal sequence for Protein Sequence type 476A (product of Applied Biosystem).

The obtained N-terminal sequences are shown in FIG. 7 SEQ ID NOS:9-13.

(3) PCR

20-30 Nucleotides primers SEQ ID NOS:14-20 for 5′-terminal of +chain and that of the−chain corresponding to the obtained N-terminal sequences were synthesized. PCR reaction was carried out in a 100-μL reaction system by use of a template DNA (100 ng), a primer (20 pmol), and PwoDNA polymerase (product of Boehringer Mannheim). When inverse PCR was performed, Expand™ long template PCR system (product of Boehringer Mannheim) was used in a 50-μL reaction system. PCR carried out by use of these primers, 9860-N2 SEQ ID NOS:14 and 9860-25k-RV SEQ ID NO:17, provided a DNA fragment of 527 bp.

(4) Subcloning of the PCR Product

The PCR product was purified with a High Pure PCR Product Purification Kit (product of Boehringer Mannheim) and inserted to the Sma I site of pUC18 through overnight reaction at 16° C. with Ligation kit ver. 2 (product of Takara). The resultant recombinant plasmid and the competent cell E. coli JM109 strain (product of Takara) were mixed, and the mixture was subjected to heat shock (42° C., 45 seconds), to thereby transform the E. coli JM109 cells. LB was added to the cells. After being maintained at 37° C. for one hour, the mixture was applied to an LB plate containing IPTG (0.1 mM, Sigma), X-gal [0.004% (w/v), Sigma], and ampicillin (50 μg/mL, Sigma). Cultivation was performed overnight at 37° C., and grown white colonies were selected as transformants having the recombinant plasmid.

(5) Determination of the Nucleotide Sequence

The transformant was cultivated overnight at 37° C. in LB containing ampicillin (50 μg/mL), and cells were collected through centrifugation. The recombinant plasmid was obtained by use of High Pure Plasmid Isolation Kit (product of Boehringer Mannheim). PCR for sequencing was performed in a 20-μL reaction system by use of a primer and a DNA sequencing kit (product of PERKIN ELMER), the obtained recombinant plasmid (1 μg) was served as a template DNA. The reaction product was purified by use of Quick Spin Column (product of Boehringer mannheim), and dried up by use of a centrifugal evaporator. The thus-treated sample was subjected to analysis by use of DNA Sequencer Type 377 (product of Applied Biosystem).

The DNA fragment obtained through PCR had the amino acid sequence which matches the N-terminal sequence of the KP-9860 protease, and there were observed sequences, which match common sequences near Asp and His among three amino acids. (Asp, His, Ser) forming an active center of alkaline protease such as subtilisin. Thus, the DNA fragment was considered to be a portion of the KP-9860 protease gene.

(6) Southern Hybridization

KP9860 chromosome was treated with EcoR I, Sac I, Kpn I, Hind III, BamH I, Xho I, Pst I, and Bgl II. Southern hybridization was performed by use of the obtained 527 bp DNA as a probe, to thereby detect a complementary region.

As a result, hybridization bands were observed in the lanes other than the lane attributed to Kpn I.

(7) Inverse PCR

Inverse PCR was performed by use of primers (1˜4 (FIG. 9) SEQ ID NOS:21-24 Synthesized from the obtained 527 bp sequence. The KP-9860 chromosome was completely digested by use of restriction enzymes, i.e., EcoRI, HindIII, PstI, and BgIII, and each sample was treated by use of Ligation Kit Ver. 2 (product of Takara)for circularization. Each of the resultant reaction mixtures was served as a template DNA for inverse PCR. PCR reaction (conditions; (94° C.-10 seconds, 60° C.-30 seconds, 68° C.-4 minutes)×10 c 68° C.-4 minutes+20×the number of cycles)×20 cycles; 68° C.-7 minutes; and 4° C.-1 minute) was performed by use of the template DNA described above (0.1 μg), primers 1 and 4 (10 pmol, respectively), and the Expand Long Plate PCR System. In addition, PCR (conditions; as described above) was performed by use of the template DNA derived from Eco RI digested chromosome (0.1 μg), primers 2 and 3 (10 pmol, respectively), and the Expand Long Plate PCR System. The resultant amplified DNA fragments were purified by use of High Pure PCR Product Purification Kit, and terminals were converted to blunt-ended by use of DNA Blunting Kit (product of Takara). Each of the obtained DNA fragments and SmaI digested pUC18 were mixed, and the mixture was treated with Ligation Kit Ver. 2. As described above, E. coli JM 109 strain was transformed by the recombinant plasmid, and the obtained recombinant plasmid was served as a template DNA for sequencing. Thus, the nucleotide sequence of the amplified DNA fragments was determined.

(8) Analysis of the Entire Nucleotide Sequence of the KP-9860 Protease Gene

The sequencing revealed that the KP-9860 protease gene contains an open reading frame (ORF) encoding the 1917 bp, 639 amino acid residues and that the ORF contains a region (NDVARHIVKADVAQSSYGLY) which SEQ ID NO:9 matches the N-terminal sequence of the purified KP9860 protease. Judging from the N-terminal sequence, the muture region of KP9860 protease gene was deduced to be the 1302 bp, encoding 434 amino acid residues SEQ ID NO:4, molecular weight 45310 Da). Upstream of the ORF, there were observed sequences which are deduced to be a promoter region (−35 region: ttgtgt, −10 region: tacgat) and a ribosome-binding site (SD sequence: aggagt). Downstream of the termination codon (taa), there was an inverted repeat having a free energy of −26.2 kcal/mol, which is deduced to be a terminator.

The procedure of Example 5 was repeated, to thereby analyze the entire nucleotide sequence and amino acid sequence of each of the genes of KP-43 protease and KP-1790 protease. The results are shown in SEQ ID NOS:4 and 5.

Example 6

Washing Test:

A washing test was carried out according to JIS K 3371. Detergents whose compositions are shown in Table 7 were dissolved in water containing 71.2 mg of CaCO₃/L (4° DH) so as to adjust the concentration, and each protease was added to detergent solution so as to adjust the concentration of the alkaline protease to 40 mAPU/L according to the Anson-Hemoglobin method (see Table 8).

Collars of shirts (worn for 3 days) were employed as specimens. For comparison, after the cloth of a collar was cut into a size of about 8×8 cm, the cloth was washed at 15° C. and 100 rpm, for 10 minutes by use of a Terg-O-Tometer (Ueshima Seisakusyo) with addition of the enzyme or without addition of the enzyme. After being rinsed and dried, pairs of collar clothes (15 pairs) were compared and evaluated by visual judgement. When the soil was almost completely cleaned, an evaluation of 5 was assigned, and when the soil was hardly cleaned, an evaluation of 1 was assigned, and the total scores of 15 specimens were calculated. The detergency index was expressed as the scores of each composition, with the detergency of a detergent composition without addition of the enzyme taken as 100. The results are shown in Table 8.

TABLE 7 (wt. %) Compound (%) Detergent A Detergent B Detergent C LAS 23.0  4.0 20.0  AS 4.0 AE 5.0 AEP 5.0 AES 20.0  Fatty acid salt 3.0 2.5 2.0 Zeolite 22.0  20.0  Sodium carbonate 15.0  Potassium carbonate 3.0 Amorphous silicate 7.0 7.0 Crystalline silicate 4.0 Sodium sulfite 2.0 0.5 2.0 Sodium sulfate 2.0 23.0  AA-MA 5.0 Citrate 10.0  PEG 2.0 2.0 Monoethanolamine 8.0 Ethanol 5.0 Water 3.0 balance 7.0 Form G* L** G* Concentration in use 20 g/30 L 20 g/30 L 40 g/30 L pH after washing 10.7  9.2 8.0 *G stands for granular. **L stands for liquid. LAS: sodium linear alkyl(C12-C14)benzene sulfonate (free acid incorporated into a liquid detergent) AS: alkyl sulfate AE: polyoxyethylene lauryl ether (average EO addition of 4 moles) AEP: polyoxyethylene polyoxypropylene lauryl ether (average EO addition of 8 mol, average PO addition of 3 mol) AES: alkyl ether sulfate (average EO addition of 2.5 mol) Fatty acid: palm oil-derived fatty acid sodium salt Zeolite: zeolite 4A, average particle size of 3 μm Sodium carbonate: dense ash Amorphous silicate: JIS No. 2 sodium silicate Crystalline silicate: pulverized SKS-6 (product of Hoechst Tokuyama), average particle size of 15 μm AA-MA: Sokalan CP5, acrylic acid-maleic acid copolymer (product of BASF) PEG: polyethylene glycol, average molecular weight of 8,000

TABLE 8 Detergency index Protease Detergent A Detergent of Bacillus sp. KSM-KP43 106 the invention 1 (Example 2) Detergent of Bacillus sp. KSM-KP1790 106 the invention 2 (Example 3) Detergent of Bacillus sp. KSM-KP9860 105 the invention 3 (Example 3) Comparative Savinase 120T type White ®   103.5 detergent 1 (Novo Nordisk) Comparative Durazym 6.0T ®   103.5 detergent 2 (Novo Nordisk) Comparative None 100 detergent 3

Table 8 demonstrates that, even under the same activity conditions, the detergent composition containing the enzyme of the present invention (detergent A) exhibits superior detergency as compared to detergents containing conventional proteases. Detergents B and C also exhibit excellent detergency of the present invention.

Example 7

A granular product was prepared through a method disclosed in Japanese Patent Application Laid-Open (kokai) No. 62-257990 by use of a purified sample of protease of the present invention which had been derived from Bacillus sp. KSM-KP43, KSM-KP1790, or KSM-KP9860 and prepared in Example 2 or 3. The granular product (6 APU/g) (1 part by weight) was incorporated into each of detergents (100 parts by weight) having compositions shown in Table 9, to thereby obtain detergent compositions of the present invention. When the detergent was of the granular type, such a detergent was prepared by blending a granular detergent base which is free of components; i.e., an enzyme, PC, AC-1, and AC-2, with a granulated enzyme, granulated PC, granulated AC-1, and granulated AC-2. Each detergent was dissolved in water containing 71.2 mg CaCO₃/L (40 DH) at a concentration for use, and a collar was washed in a manner as described in Example 6. The detergents produced herein exhibit excellent washing power, and are useful for a laundry detergent.

TABLE 9 Component Detergents of the present invention (%) 4 5 6 7 8 9 10 11 12 13 LAS-2 20 20.5 12 5 10 LAS-3 15 AS-2 5 10 20 SAS 3 AOS 3 SFE 8 Fatty acid 2 6 4 10 3 3 2 1.5 salt AES-2 20 AE-3 3 10 AE-4 3 3 15 15 3 15 AE-5 2 20 20 25 AG 5 7 Zeolite 30 18 15 15 10 20 Oil- 10 12 absorbing carrier Crystalline 20 silicate Amorphous 12 1 8 10 5 silicate STPP 25.5 20 Sodium 10 27 25 10 10 15 17.5 0.1 carbonate Potassium 3 2 5 carbonate Sodium 2 2 1 0.2 0.2 0.2 sulfite Sodium 4.5 1.5 1 11 8 10 sulfate Sodium 4 2 5 1.5 1 1 citrate NTA 2 Monoethanol 4 5 6 -amine PAA 1 1.5 3 AA-MA 3 3 5 CMC 2 PEG 5 2 2 2 2 1.5 PVP 2 Fluorescent 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 dye Perfume 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 Water 4 5 3 0.5 6 1 5 43.7 38.2 30.2 Ethanol 5 5 5 Propylene 2 5 5 glycol Enzyme 2 2 2 3 3 2 2 0.1 0.2 0.2 PC 3 3 10 3 AC-1 2 AC-2 1 Total 100 100 100 100 100 100 100 100 100 100 Form G* G* G* G* G* G* G* L** L** L** Concentra- 20 g/ 20 g/ 20 g/ 20 g/ 20 g/ 20 g/ 20 g/ 20 mL/ 20 mL/ 20 mL/ tion in 30 L 30 L 30 L 30 L 30 L 30 L 30 L 30 L 30 L 30 L use *G stands for granular. **L stands for liquid. LSA-2: alkylbenzene sulfonic acid (C10-C14 alkyl chain) which was neutralized with 48% NaOH LSA-3: alkylbenzene sulfonic acid (C10-C14 alkyl chain) which was neutralized with 50% NaOH AS-2: sodium salt of Dovanol 25 sulfate (C12-C15 sulfate) SAS: sodium C13-C18 alkane sulfonate AOS: sodium α-olefin sulfonate SFE: sodium salt of palm oil α-sulfofatty acid methyl ester Fatty acid salt: sodium palmitate AES-2: sodium polyoxyethylene alkyl (C12-C15) ether sulfate (average EO addition of 2 moles) AE-3: EO adduct (average 3 moles) of C12-C13 alcohol AE-4: EO adduct (average 7.2 moles) of C12-C15 alcohol AE-5: EO adduct (average 7 moles) of C12-C15 secondary alcohol AG: alkyl (palm oil-derived) glucoside (average polymerization degree of 1.5) Oil-absorbing carrier: Amorphous sodium aluminosilicate, oil absorption of 235 mL/100 g Crystalline silicate: SKS-6 (δ-Na₂Si₂O₅, crystalline layered silicate, average particle size of 20 μm) Amorphous silicate: JIS No. 1 sodium silicate STPP: sodium tripolyphosphate NTA: sodium nitrilotriacetate PAA: sodium salt of poly(acrylic acid), average molecular weight of 12,000 AA-MA: acrylic acid/maleic acid copolymer CMC: carboxymethyl cellulose sodium PEG: polyethylene glycol, average molecular weight of 6,000 PVA: polyvinylpyrrolidone, average molecular weight of 40,000, K value of 26-35 Fluorescent dye: Tinopal CBS and Whitex SA (1:1 (wt.)), only Cinopearl incorporated into a liquid detergent Perfume: A perfume composition disclosed in Japanese Patent Application Laid-Open (kokai) No. 8-239700 Enzyme: Lipolase 100T, Termamyl 60T, and KAC 500 ® (product of Kao Corporation) 1:1:1 (wt.) PC: sodium percarbonate, average particle size of 400 μm, coated with sodium metaborate AC-1: tetraacetylethylenediamine AC-2: sodium lauroyloxybenzene sulfonate

Example 8

Among the components shown in Table 10, sodium percarbonate and sodium carbonate (dense ash) were mixed with stirring. To the mixture, a 40% aqueous solution of sodium polyacrylate and sodium linear alkylbenzene sulfonate (or nonionic surfactant or sodium lauroyloxybenzene sulfonate) were added. Subsequently, a granulation product of alkaline protease which had been derived from Bacillus sp. KSM-KP43 and prepared in Example 7 was added to the mixture. The resultant mixture was homogeneously stirred, to thereby prepare a bleaching agent. A collar was immersed in a 0.5% aqueous solution of each of the bleaching agents at 20° C. for 30 minutes, and subsequently washed with detergent A (Example 6) in a Terg-O-Tometer at 100 rpm for 10 minutes at 20° C. The obtained bleaching agents have excellent bleaching ability, and are useful as a bleaching agent for laundry.

TABLE 10 (wt. %) Bleaching agents of the present invention Component 14 15 16 17 Sodium percarbonate¹⁾ 80.0 80.0 80.0 80.0 Sodium carbonate 16.0 12.0 16.0 12.0 (dense ash) Anionic surfactant²⁾ 2.0 2.0 — — Nonionic surfactant³⁾ — — 2.0 2.0 Sodium polyacrylate⁴⁾ 1.0 1.0 1.0 1.0 Sodium lauroyloxy- — 4.0 — 4.0 benzene sulfonate Bacillus sp. KSM-KP43 1.0 1.0 1.0 1.0 Alkaline protease (Ex. 7) ¹⁾Particle size: 500-700 μm ²⁾Sodium linear alkylbenzene sulfonate (C12-C14) ³⁾Polyoxyethylene alkyl ether (C12-C14 alkyl, average EO addition of 12 mol) ⁴⁾Average molecular weight of 8,000

Example 9

The procedure of Example 8 was repeated, to thereby prepare detergent compositions for an automated dishwasher having a composition shown in Table 11. Washing power of the obtained compositions was tested under the following conditions. The obtained detergents have excellent washing power, and are useful as a detergent for an automated dishwasher.

TABLE 11 (wt. %) Detergents of the present invention Component 18 19 20 21 Pluronic L-61¹⁾ 4 — 4 4 Softanol EP-7085²⁾ — 4 — — Trisodium citrate 30 30 — — EDTA — — 30 — Sodium tripoly- — — — 30 phosfate Sodium percarbonate 20 20 20 20 Sodium carbonate 20 20 20 20 (dense ash) Amorphous silicate³⁾ 10 10 10 10 AA-MA⁴⁾ 4 4 4 4 Sodium sulfate 10 10 10 10 Lipolase 100T ® 0.5 0.5 0.5 0.5 (Novo Nordisk) Termamyl 60T ® 1 1 1 1 (Novo Nordisk) Bacillus sp. KSM-KP43 0.5 0.5 0.5 0.5 alkaline protease (Ex. 7) ¹⁾Polyoxyethylene-polyoxypropylene copolymer (average molecular weight of 2,000) ²⁾Ethylene oxide (7 moles) and propylene oxide (8.5 moles) adduct of C12-C14 sec-alcohol ³⁾JIS No. 2 sodium silicate ⁴⁾Acrylic acid-maleic acid copolymer

(1) Preparation of a Soiled Dish

Egg yolk (2.5 g) was homogeneously brushed onto one ceramic dish having a diameter of 25 cm. The dish was dried in a drier at 115° C. for 60 minutes.

(2) Washing Conditions

Washer used; Full automated dishwasher (NP-810, product of Matsushita Electric Industry Co., Ltd.)

Type of washing; Standard course

Water for washing; Hardness of 62.3 mg CaCO₃/L (3.5° DH)

Concentration of detergent; 0.2 wt. %

(3) Method for Evaluation

Five soiled dishes were washed in the washer under the above conditions by use of the detergent compositions of Example 9. The washed dish was stained with a 1% Erythrosine solution, to thereby color residual protein. The degree of protein soil was judged visually.

Example 10

Detergent compositions for an automated dishwasher were obtained from components shown in Table 12. Washing power of these compositions were evaluated through a test similar to that of Example 9. The compositions provided an excellent washing effect.

TABLE 12 (wt. %) Detergent compositions of the present invention Component 22 23 24 25 26 (a) Sodium carbonate 30 30 50 Sodium hydrogen- 25 25 carbonate (b) Sokalan CP5¹⁾ 5 6 5 5 5 (c) Sodium hydrogen- 5 6 percarbonate (d) Limonene 2 2 1 1 Softanol EP7045²⁾ 2 1 1 (c) Amorphous sodium 2 2 1 3 aluminosilicate (Synth. Ex. 1)³⁾ Amorphous sodium 2 1 aluminosilicate (Synth. Ex. 2)⁴⁾ Lipolase 100T ® 0.5 0.5 0.5 0.5 0.5 (Novo Nordisk) Termamyl 60T ® 1 1 1 1 1 (Novo Nordisk) Bacillus sp. KSM-KP43 0.5 0.5 0.5 0.5 0.5 alkaline protease (Ex. 7) Sodium malate 10 5 Sodium citrate 15 10 4 8 Sodium sulfate 39 53 43 55 30 ¹⁾Acrylic acid/maleic acid copolymer (product of BASF) ²⁾Ethylene oxide (7 moles) and propylene oxide (4.5 moles)adduct of C12-C14 sec-alcohol ^(3), 4))Synthetic Example disclosed in Japanese Patent Application Laid-Open (kokai) No. 6-179899

Example 11

Enzymes were added to the above-described detergent A (Example 6) in amounts shown in the following Table 13. A collar portion of a white shirt was washed in a manner similar to that of Example 6.

TABLE 13 (wt. %) Detergents of the present invention Enzyme 27 28 29 30 31 32 33 Protease of the present — 0.5 0.5 0.5 0.5 0.5 0.5 invention¹⁾ Conventional protease²⁾ — — 0.6 — — 0.6 0.6 Cellulase³⁾ — — — 0.7 — 0.7 0.7 Lipase⁴⁾ — — — — 0.5 — 0.5 ¹⁾A granular product prepared through a method disclosed in Japanese Patent Application Laid-Open (kokai) No. 62-257990 by use of a purified sample of protease of the present invention which was derived from Bacillus sp. KSM-KP 43 strain and prepared in Example 2 (6 APU/g) ²⁾Protease K-16 disclosed in Japanese Patent Appliaation Laid-Open (kokai) N0.5-25492 which was modified to have 5 APU/g through a method disclosed in Japanese Patent Application Laid-Open (kokai) No. 62-257990 ³⁾KAC-500 ® (cellulase, 500 U/g, product of Kao Corporation) ⁴⁾Lipolase 100T ® (product of Novo Nordisk)

The results clearly show that the combination of the protease of the present invention and a conventional protease, cellulose, or lipase enhances a washing effect.

Industrial Applicability

The alkaline protease of the present invention has excellent stability against a variety of surfactants; resistance to fatty acids; and high stability against an oxidizing agent, and is therefore useful as an enzyme for a detergent for an automated dishwasher and for a laundry detergent, both containing a bleaching component.

24 1 639 PRT Bacillus sp. misc_feature (23)..(23) Xaa is any amino acid 1 Met Arg Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala Ile 1 5 10 15 Leu Ser Thr Val Ala Leu Xaa Asn Pro Ser Ala Gly Xaa Ala Arg Xaa 20 25 30 Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Xaa Xaa Gly 35 40 45 Phe Ser Lys Gln Xaa Gln Thr Gly Ala Ala Ala Phe Leu Val Glu Ser 50 55 60 Glu Asn Val Lys Leu Xaa Lys Gly Leu Xaa Lys Lys Leu Glu Thr Val 65 70 75 80 Pro Ala Asn Asn Lys Leu His Ile Xaa Gln Phe Asn Gly Pro Ile Leu 85 90 95 Glu Glu Thr Lys Gln Xaa Leu Glu Xaa Thr Gly Ala Lys Ile Leu Asp 100 105 110 Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val Xaa 115 120 125 Ser Xaa Xaa Xaa Xaa Ile Glu His Val Glu Ser Val Glu Pro Tyr Leu 130 135 140 Pro Xaa Tyr Xaa Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser Xaa 145 150 155 160 Leu Val Lys Ala Xaa Ala Leu Asp Thr Lys Gln Xaa Asn Lys Glu Val 165 170 175 Gln Leu Arg Gly Ile Glu Xaa Ile Ala Gln Xaa Xaa Xaa Ser Asn Asp 180 185 190 Val Xaa Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp Val 195 200 205 Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly Leu 210 215 220 Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp Thr 225 230 235 240 Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile Thr 245 250 255 Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn Gly 260 265 270 His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Xaa Thr Asn 275 280 285 Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met Asp 290 295 300 Ser Xaa Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu Phe 305 310 315 320 Ser Gln Ala Xaa Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp Gly 325 330 335 Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp Asp 340 345 350 Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn Glu 355 360 365 Xaa Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn Ala 370 375 380 Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser Tyr 385 390 395 400 Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro Thr 405 410 415 Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Xaa Ile 420 425 430 Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala Asn 435 440 445 His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr Pro 450 455 460 Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys Asn 465 470 475 480 Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile Ala 485 490 495 Gly Ala Ala Asp Xaa Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly Trp 500 505 510 Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn Glu 515 520 525 Ser Ser Xaa Leu Ser Thr Ser Gln Lys Ala Thr Tyr Xaa Phe Thr Ala 530 535 540 Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala Pro 545 550 555 560 Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu Val 565 570 575 Ile Thr Ala Pro Asn Gly Thr Xaa Tyr Val Gly Asn Asp Phe Xaa Xaa 580 585 590 Pro Xaa Xaa Xaa Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val Phe 595 600 605 Ile Asn Xaa Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala Tyr 610 615 620 Asn Val Pro Val Gly Pro Gln Xaa Phe Ser Leu Ala Ile Val Asn 625 630 635 2 640 PRT Bacillus sp. misc_feature (3)..(3) Xaa is any amino acid 2 Met Arg Xaa Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala 1 5 10 15 Ile Leu Ser Thr Val Ala Leu Xaa Asn Pro Ser Ala Gly Xaa Ala Arg 20 25 30 Xaa Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Xaa Xaa 35 40 45 Gly Phe Ser Lys Gln Xaa Gln Thr Gly Ala Ala Ala Phe Leu Val Glu 50 55 60 Ser Glu Asn Val Lys Leu Xaa Lys Gly Leu Xaa Lys Lys Leu Glu Thr 65 70 75 80 Val Pro Ala Asn Asn Lys Leu His Ile Xaa Gln Phe Asn Gly Pro Ile 85 90 95 Leu Glu Glu Thr Lys Gln Xaa Leu Glu Xaa Thr Gly Ala Lys Ile Leu 100 105 110 Asp Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val 115 120 125 Xaa Ser Xaa Xaa Xaa Xaa Ile Glu His Val Glu Ser Val Glu Pro Tyr 130 135 140 Leu Pro Xaa Tyr Xaa Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser 145 150 155 160 Xaa Leu Val Lys Ala Xaa Ala Leu Asp Thr Lys Gln Xaa Asn Lys Glu 165 170 175 Val Gln Leu Arg Gly Ile Glu Xaa Ile Ala Gln Xaa Xaa Xaa Ser Asn 180 185 190 Asp Val Xaa Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp 195 200 205 Val Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly 210 215 220 Leu Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp 225 230 235 240 Thr Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile 245 250 255 Thr Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn 260 265 270 Gly His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Xaa Thr 275 280 285 Asn Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met 290 295 300 Asp Ser Xaa Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu 305 310 315 320 Phe Ser Gln Ala Xaa Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp 325 330 335 Gly Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp 340 345 350 Asp Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn 355 360 365 Glu Xaa Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn 370 375 380 Ala Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser 385 390 395 400 Tyr Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro 405 410 415 Thr Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Xaa 420 425 430 Ile Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala 435 440 445 Asn His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr 450 455 460 Pro Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys 465 470 475 480 Asn Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile 485 490 495 Ala Gly Ala Ala Asp Xaa Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly 500 505 510 Trp Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn 515 520 525 Glu Ser Ser Xaa Leu Ser Thr Ser Gln Lys Ala Thr Tyr Xaa Phe Thr 530 535 540 Ala Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala 545 550 555 560 Pro Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu 565 570 575 Val Ile Thr Ala Pro Asn Gly Thr Xaa Tyr Val Gly Asn Asp Phe Xaa 580 585 590 Xaa Pro Xaa Xaa Xaa Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val 595 600 605 Phe Ile Asn Xaa Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala 610 615 620 Tyr Asn Val Pro Val Gly Pro Gln Xaa Phe Ser Leu Ala Ile Val Asn 625 630 635 640 3 1920 DNA Bacillus sp. CDS (1)..(1920) 3 atg aga aag aag aag gtg ttt tta tct gtt tta tca gct gca gcg att 48 Met Arg Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala Ile 1 5 10 15 ctg tcg act gtt gca tta aac aat ccc tcg gct ggt gat gca agg act 96 Leu Ser Thr Val Ala Leu Asn Asn Pro Ser Ala Gly Asp Ala Arg Thr 20 25 30 ttt gat ctg gat ttt aaa gga att caa aca aca acc gat gtc agt ggt 144 Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Val Ser Gly 35 40 45 ttc tcc aaa cag cga caa aca ggt gcg gct gca ttt ctg gtg gag tct 192 Phe Ser Lys Gln Arg Gln Thr Gly Ala Ala Ala Phe Leu Val Glu Ser 50 55 60 gaa aat gtg aaa ctt ctt aaa gga ttg cta aag aaa ctt gaa aca gta 240 Glu Asn Val Lys Leu Leu Lys Gly Leu Leu Lys Lys Leu Glu Thr Val 65 70 75 80 ccg gca aat aat aaa ctc cat att gtc caa ttc aat ggc ccc att tta 288 Pro Ala Asn Asn Lys Leu His Ile Val Gln Phe Asn Gly Pro Ile Leu 85 90 95 gaa gaa aca aaa cag aag cta gag aca act gga gca aag att ctc gac 336 Glu Glu Thr Lys Gln Lys Leu Glu Thr Thr Gly Ala Lys Ile Leu Asp 100 105 110 tac atc cct gat tat gca tat att gtc gag tat gag ggg gat gtt cag 384 Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val Gln 115 120 125 tca aaa gtc cgc tcc att gaa cac gtg gaa tca gtg gag cca tac ttg 432 Ser Lys Val Arg Ser Ile Glu His Val Glu Ser Val Glu Pro Tyr Leu 130 135 140 ccg aaa tac aaa ata gat ccc cag ctt ttc aca aaa ggc gca tcg acg 480 Pro Lys Tyr Lys Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser Thr 145 150 155 160 ctg gtg aaa gcg ttg gcg ctt gat acg aag cag aac aat aaa gaa gtg 528 Leu Val Lys Ala Leu Ala Leu Asp Thr Lys Gln Asn Asn Lys Glu Val 165 170 175 caa tta aga ggc atc gag gaa atc gct cag tac gta gca agc aat gac 576 Gln Leu Arg Gly Ile Glu Glu Ile Ala Gln Tyr Val Ala Ser Asn Asp 180 185 190 gtc cat tat att acg gca aag cct gaa tat aag gtg atg aat gat gtg 624 Val His Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp Val 195 200 205 gcc aga ggt att gtc aaa gcg gat gtg gca cag agc agc tac ggt ttg 672 Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly Leu 210 215 220 tat gga caa ggc cag att gtc gca gtt gcc gat act gga ttg gat aca 720 Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp Thr 225 230 235 240 gga aga aac gac agt tcg atg cat gaa gcc ttc cgc ggt aaa ata aca 768 Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile Thr 245 250 255 gca cta tat gca ctg ggt cgg acg aat aat gcg aat gat acg aac ggt 816 Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn Gly 260 265 270 cat ggt acc cat gtg gca ggt tcg gta tta gga aat ggc gca acg aat 864 His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Ala Thr Asn 275 280 285 aaa gga atg gca cct caa gcg aat ctg gtt ttt caa tcc atc atg gat 912 Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met Asp 290 295 300 agc agt ggt ggg ctt gga ggc ttg cct tcc aat ctg caa acc tta ttc 960 Ser Ser Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu Phe 305 310 315 320 agc caa gca ttc agt gca ggt gcc aga att cat aca aac tcc tgg ggg 1008 Ser Gln Ala Phe Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp Gly 325 330 335 gca gcg gtg aat ggg gcc tac acg aca gat tcc aga aat gtg gat gac 1056 Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp Asp 340 345 350 tat gta agg aaa aat gat atg acg att ctt ttc gcg gct ggg aat gaa 1104 Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn Glu 355 360 365 agg ccg aac ggc ggt acc atc agt gca cct ggt acg gct aaa aac gcc 1152 Arg Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn Ala 370 375 380 ata aca gtc ggc gca acc gaa aac ctg cgt cca agc ttc ggt tcc tat 1200 Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser Tyr 385 390 395 400 gca gat aat att aac cac gtt gca cag ttc tct tcc cgt ggc ccg aca 1248 Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro Thr 405 410 415 aaa gat ggg cga atc aag cct gat gtc atg gcg cca ggg aca tac att 1296 Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Tyr Ile 420 425 430 tta tca gca aga tct tct ctt gca ccc gat tcc tcc ttc tgg gcg aat 1344 Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala Asn 435 440 445 cat gac agc aaa tat gcc tat atg ggt gga acg tcc atg gca aca ccg 1392 His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr Pro 450 455 460 att gtt gcg ggg aat gtt gca cag ctc cgt gag cat ttt gtg aaa aat 1440 Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys Asn 465 470 475 480 aga gga atc act cct aag cct tcc cta ttg aaa gca gct ttg att gca 1488 Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile Ala 485 490 495 ggt gct gct gat gtt gga ttg ggt tat ccg aac gga aac caa gga tgg 1536 Gly Ala Ala Asp Val Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly Trp 500 505 510 ggc cga gtg acc ctg gat aaa tcg ttg aac gtt gcc tat gtg aac gaa 1584 Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn Glu 515 520 525 tcc agt gcc cta tca act agc caa aaa gcg aca tat acc ttt act gca 1632 Ser Ser Ala Leu Ser Thr Ser Gln Lys Ala Thr Tyr Thr Phe Thr Ala 530 535 540 acg gcg ggc aag cca ttg aaa atc tcc ctg gta tgg tcg gat gcc cct 1680 Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala Pro 545 550 555 560 gca agc act act gct tct gta acc ctg gtc aat gat ttg gat ttg gtc 1728 Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu Val 565 570 575 att aca gca cca aac gga aca aga tat gtc ggg aat gac ttc tca gca 1776 Ile Thr Ala Pro Asn Gly Thr Arg Tyr Val Gly Asn Asp Phe Ser Ala 580 585 590 cca ttt gac aat aac tgg gat ggc cgc aat aac gta gaa aat gta ttt 1824 Pro Phe Asp Asn Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val Phe 595 600 605 att aat tcg ccc caa agt gga aca tat acc att gag gtg caa gca tat 1872 Ile Asn Ser Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala Tyr 610 615 620 aat gtg ccg gtt gga cca caa aac ttc tcg ttg gca att gtg aac taa 1920 Asn Val Pro Val Gly Pro Gln Asn Phe Ser Leu Ala Ile Val Asn 625 630 635 4 639 PRT Bacillus sp. 4 Met Arg Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala Ile 1 5 10 15 Leu Ser Thr Val Ala Leu Asn Asn Pro Ser Ala Gly Asp Ala Arg Thr 20 25 30 Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Val Ser Gly 35 40 45 Phe Ser Lys Gln Arg Gln Thr Gly Ala Ala Ala Phe Leu Val Glu Ser 50 55 60 Glu Asn Val Lys Leu Leu Lys Gly Leu Leu Lys Lys Leu Glu Thr Val 65 70 75 80 Pro Ala Asn Asn Lys Leu His Ile Val Gln Phe Asn Gly Pro Ile Leu 85 90 95 Glu Glu Thr Lys Gln Lys Leu Glu Thr Thr Gly Ala Lys Ile Leu Asp 100 105 110 Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val Gln 115 120 125 Ser Lys Val Arg Ser Ile Glu His Val Glu Ser Val Glu Pro Tyr Leu 130 135 140 Pro Lys Tyr Lys Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser Thr 145 150 155 160 Leu Val Lys Ala Leu Ala Leu Asp Thr Lys Gln Asn Asn Lys Glu Val 165 170 175 Gln Leu Arg Gly Ile Glu Glu Ile Ala Gln Tyr Val Ala Ser Asn Asp 180 185 190 Val His Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp Val 195 200 205 Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly Leu 210 215 220 Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp Thr 225 230 235 240 Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile Thr 245 250 255 Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn Gly 260 265 270 His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Ala Thr Asn 275 280 285 Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met Asp 290 295 300 Ser Ser Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu Phe 305 310 315 320 Ser Gln Ala Phe Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp Gly 325 330 335 Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp Asp 340 345 350 Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn Glu 355 360 365 Arg Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn Ala 370 375 380 Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser Tyr 385 390 395 400 Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro Thr 405 410 415 Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Tyr Ile 420 425 430 Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala Asn 435 440 445 His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr Pro 450 455 460 Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys Asn 465 470 475 480 Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile Ala 485 490 495 Gly Ala Ala Asp Val Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly Trp 500 505 510 Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn Glu 515 520 525 Ser Ser Ala Leu Ser Thr Ser Gln Lys Ala Thr Tyr Thr Phe Thr Ala 530 535 540 Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala Pro 545 550 555 560 Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu Val 565 570 575 Ile Thr Ala Pro Asn Gly Thr Arg Tyr Val Gly Asn Asp Phe Ser Ala 580 585 590 Pro Phe Asp Asn Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val Phe 595 600 605 Ile Asn Ser Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala Tyr 610 615 620 Asn Val Pro Val Gly Pro Gln Asn Phe Ser Leu Ala Ile Val Asn 625 630 635 5 1923 DNA Bacillus sp. CDS (1)..(1923) 5 atg aga aag aag aaa aag gtg ttt tta tct gtt tta tca gct gca gcg 48 Met Arg Lys Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala 1 5 10 15 att ttg tcg act gtt gcg tta agt aat cca tct gca ggt ggt gca agg 96 Ile Leu Ser Thr Val Ala Leu Ser Asn Pro Ser Ala Gly Gly Ala Arg 20 25 30 aat ttt gat ctg gat ttc aaa gga att cag aca aca act gat gct aaa 144 Asn Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Ala Lys 35 40 45 ggt ttc tcc aag cag ggg cag act ggt gct gct gct ttt ctg gtg gaa 192 Gly Phe Ser Lys Gln Gly Gln Thr Gly Ala Ala Ala Phe Leu Val Glu 50 55 60 tct gaa aat gtg aaa ctc cca aaa ggt ttg cag aag aag ctt gaa aca 240 Ser Glu Asn Val Lys Leu Pro Lys Gly Leu Gln Lys Lys Leu Glu Thr 65 70 75 80 gtc ccg gca aat aat aaa ctc cat att atc caa ttc aat gga cca att 288 Val Pro Ala Asn Asn Lys Leu His Ile Ile Gln Phe Asn Gly Pro Ile 85 90 95 tta gaa gaa aca aaa cag cag ctg gaa aaa aca ggg gca aag att ctc 336 Leu Glu Glu Thr Lys Gln Gln Leu Glu Lys Thr Gly Ala Lys Ile Leu 100 105 110 gac tac ata cct gat tat gct tac att gtc gag tat gag ggc gat gtt 384 Asp Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val 115 120 125 aag tca gca aca agc acc att gag cac gtg gaa tcc gtg gag cct tat 432 Lys Ser Ala Thr Ser Thr Ile Glu His Val Glu Ser Val Glu Pro Tyr 130 135 140 ttg ccg ata tac aga ata gat ccc cag ctt ttc aca aaa ggg gca tca 480 Leu Pro Ile Tyr Arg Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser 145 150 155 160 gag ctt gta aaa gca gtg gcg ctt gat aca aag cag aaa aat aaa gag 528 Glu Leu Val Lys Ala Val Ala Leu Asp Thr Lys Gln Lys Asn Lys Glu 165 170 175 gtg caa tta aga ggc atc gaa caa atc gca caa ttc gca ata agc aat 576 Val Gln Leu Arg Gly Ile Glu Gln Ile Ala Gln Phe Ala Ile Ser Asn 180 185 190 gat gtg cta tat att acg gca aag cct gag tat aag gtg atg aat gat 624 Asp Val Leu Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp 195 200 205 gtt gcg cgt gga att gtc aaa gcg gat gtg gct cag agc agc tac ggg 672 Val Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly 210 215 220 ttg tat gga caa gga cag atc gta gcg gtt gcc gat aca ggg ctt gat 720 Leu Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp 225 230 235 240 aca ggt cgc aat gac agt tcg atg cat gaa gcc ttc cgc ggg aaa att 768 Thr Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile 245 250 255 act gca tta tat gca ttg gga cgg acg aat aat gcc aat gat acg aat 816 Thr Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn 260 265 270 ggt cat ggt acg cat gtg gct ggc tcc gta tta gga aac ggc tcc act 864 Gly His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Ser Thr 275 280 285 aat aaa gga atg gcg cct cag gcg aat cta gtc ttc caa tct atc atg 912 Asn Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met 290 295 300 gat agc ggt ggg gga ctt gga gga cta cct tcg aat ctg caa acc tta 960 Asp Ser Gly Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu 305 310 315 320 ttc agc caa gca tac agt gct ggt gcc aga att cat aca aac tcc tgg 1008 Phe Ser Gln Ala Tyr Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp 325 330 335 gga gca gca gtg aat ggg gct tac aca aca gat tcc aga aat gtg gat 1056 Gly Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp 340 345 350 gac tat gtg cgc aaa aat gat atg acg atc ctt ttc gct gcc ggg aat 1104 Asp Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn 355 360 365 gaa gga ccg aac ggc gga acc atc agt gca cca ggc aca gct aaa aat 1152 Glu Gly Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn 370 375 380 gca ata aca gtc gga gct acg gaa aac ctc cgc cca agc ttt ggg tct 1200 Ala Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser 385 390 395 400 tat gcg gac aat atc aac cat gtg gca cag ttc tct tca cgt gga ccg 1248 Tyr Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro 405 410 415 aca aag gat gga cgg atc aaa ccg gat gtc atg gca ccg gga acg ttc 1296 Thr Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Phe 420 425 430 ata cta tca gca aga tct tct ctt gca ccg gat tcc tcc ttc tgg gcg 1344 Ile Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala 435 440 445 aac cat gac agt aaa tat gca tac atg ggt gga acg tcc atg gct aca 1392 Asn His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr 450 455 460 ccg atc gtt gct gga aac gtg gca cag ctt cgt gag cat ttt gtg aaa 1440 Pro Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys 465 470 475 480 aac aga ggc atc aca cca aag cct tct cta tta aaa gcg gca ctg att 1488 Asn Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile 485 490 495 gcc ggt gca gct gac atc ggc ctt ggc tac ccg aac ggt aac caa gga 1536 Ala Gly Ala Ala Asp Ile Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly 500 505 510 tgg gga cga gtg aca ttg gat aaa tcc ctg aac gtt gcc tat gtg aac 1584 Trp Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn 515 520 525 gag tcc agt tct cta tcc acc agc caa aaa gcg acg tac tcg ttt act 1632 Glu Ser Ser Ser Leu Ser Thr Ser Gln Lys Ala Thr Tyr Ser Phe Thr 530 535 540 gct act gcc ggc aag cct ttg aaa atc tcc ctg gta tgg tct gat gcc 1680 Ala Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala 545 550 555 560 cct gcg agc aca act gct tcc gta acg ctt gtc aat gat ctg gac ctt 1728 Pro Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu 565 570 575 gtc att acc gct cca aat ggc aca cag tat gta gga aat gac ttt act 1776 Val Ile Thr Ala Pro Asn Gly Thr Gln Tyr Val Gly Asn Asp Phe Thr 580 585 590 tcg cca tac aat gat aac tgg gat ggc cgc aat aac gta gaa aat gta 1824 Ser Pro Tyr Asn Asp Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val 595 600 605 ttt att aat gca cca caa agc ggg acg tat aca att gag gta cag gct 1872 Phe Ile Asn Ala Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala 610 615 620 tat aac gta ccg gtt gga cca cag acc ttc tcg ttg gca att gtg aat 1920 Tyr Asn Val Pro Val Gly Pro Gln Thr Phe Ser Leu Ala Ile Val Asn 625 630 635 640 taa 1923 6 640 PRT Bacillus sp. 6 Met Arg Lys Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala 1 5 10 15 Ile Leu Ser Thr Val Ala Leu Ser Asn Pro Ser Ala Gly Gly Ala Arg 20 25 30 Asn Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Ala Lys 35 40 45 Gly Phe Ser Lys Gln Gly Gln Thr Gly Ala Ala Ala Phe Leu Val Glu 50 55 60 Ser Glu Asn Val Lys Leu Pro Lys Gly Leu Gln Lys Lys Leu Glu Thr 65 70 75 80 Val Pro Ala Asn Asn Lys Leu His Ile Ile Gln Phe Asn Gly Pro Ile 85 90 95 Leu Glu Glu Thr Lys Gln Gln Leu Glu Lys Thr Gly Ala Lys Ile Leu 100 105 110 Asp Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val 115 120 125 Lys Ser Ala Thr Ser Thr Ile Glu His Val Glu Ser Val Glu Pro Tyr 130 135 140 Leu Pro Ile Tyr Arg Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser 145 150 155 160 Glu Leu Val Lys Ala Val Ala Leu Asp Thr Lys Gln Lys Asn Lys Glu 165 170 175 Val Gln Leu Arg Gly Ile Glu Gln Ile Ala Gln Phe Ala Ile Ser Asn 180 185 190 Asp Val Leu Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp 195 200 205 Val Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly 210 215 220 Leu Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp 225 230 235 240 Thr Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile 245 250 255 Thr Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn 260 265 270 Gly His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Ser Thr 275 280 285 Asn Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met 290 295 300 Asp Ser Gly Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu 305 310 315 320 Phe Ser Gln Ala Tyr Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp 325 330 335 Gly Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp 340 345 350 Asp Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn 355 360 365 Glu Gly Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn 370 375 380 Ala Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser 385 390 395 400 Tyr Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro 405 410 415 Thr Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Phe 420 425 430 Ile Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala 435 440 445 Asn His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr 450 455 460 Pro Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys 465 470 475 480 Asn Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile 485 490 495 Ala Gly Ala Ala Asp Ile Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly 500 505 510 Trp Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn 515 520 525 Glu Ser Ser Ser Leu Ser Thr Ser Gln Lys Ala Thr Tyr Ser Phe Thr 530 535 540 Ala Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala 545 550 555 560 Pro Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu 565 570 575 Val Ile Thr Ala Pro Asn Gly Thr Gln Tyr Val Gly Asn Asp Phe Thr 580 585 590 Ser Pro Tyr Asn Asp Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val 595 600 605 Phe Ile Asn Ala Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala 610 615 620 Tyr Asn Val Pro Val Gly Pro Gln Thr Phe Ser Leu Ala Ile Val Asn 625 630 635 640 7 1923 DNA Bacillus sp. CDS (1)..(1923) 7 atg aga aag aag aaa aag gtg ttt tta tct gtt tta tca gct gca gcg 48 Met Arg Lys Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala 1 5 10 15 att ttg tcg act gtt gcg tta agt aat cca tct gca ggt ggt gca agg 96 Ile Leu Ser Thr Val Ala Leu Ser Asn Pro Ser Ala Gly Gly Ala Arg 20 25 30 aat ttt gat ctg gat ttc aaa gga att cag aca aca act gat gct aaa 144 Asn Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Ala Lys 35 40 45 ggt ttc tcc aag cag ggg cag act ggt gct gct gct ttt ctg gtg gaa 192 Gly Phe Ser Lys Gln Gly Gln Thr Gly Ala Ala Ala Phe Leu Val Glu 50 55 60 tct gaa aat gtg aaa ctc cca aaa ggt ttg cag aag aag ctt gaa aca 240 Ser Glu Asn Val Lys Leu Pro Lys Gly Leu Gln Lys Lys Leu Glu Thr 65 70 75 80 gtc ccg gca aat aat aaa ctc cat att atc caa ttc aat gga cca att 288 Val Pro Ala Asn Asn Lys Leu His Ile Ile Gln Phe Asn Gly Pro Ile 85 90 95 tta gaa gaa aca aaa cag cag ctg gaa aaa aca ggg gca aag att ctc 336 Leu Glu Glu Thr Lys Gln Gln Leu Glu Lys Thr Gly Ala Lys Ile Leu 100 105 110 gac tac ata cct gat tat gct tac att gtc gag tat gag ggc gat gtt 384 Asp Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val 115 120 125 aag tca gca aca agc acc att gag cac gtg gaa tcc gtg gag cct tat 432 Lys Ser Ala Thr Ser Thr Ile Glu His Val Glu Ser Val Glu Pro Tyr 130 135 140 ttg ccg ata tac aga ata gat ccc cag ctt ttc aca aaa ggg gca tca 480 Leu Pro Ile Tyr Arg Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser 145 150 155 160 gag ctt gta aaa gca gtg gcg ctt gat aca aag cag aaa aat aaa gag 528 Glu Leu Val Lys Ala Val Ala Leu Asp Thr Lys Gln Lys Asn Lys Glu 165 170 175 gtg caa tta aga ggc atc gaa caa atc gca caa ttc gca ata agc aat 576 Val Gln Leu Arg Gly Ile Glu Gln Ile Ala Gln Phe Ala Ile Ser Asn 180 185 190 gat gtg cta tat att acg gca aag cct gag tat aag gtg atg aat gat 624 Asp Val Leu Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp 195 200 205 gtt gcg cgt gga att gtc aaa gcg gat gtg gct cag agc agc tac ggg 672 Val Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly 210 215 220 ttg tat gga caa gga cag atc gta gcg gtt gcc gat aca ggg ctt gat 720 Leu Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp 225 230 235 240 aca ggt cgc aat gac agt tcg atg cat gaa gcc ttc cgc ggg aaa att 768 Thr Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile 245 250 255 act gca tta tat gca ttg gga cgg acg aat aat gcc aat gat acg aat 816 Thr Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn 260 265 270 ggt cat ggt acg cat gtg gct ggc tcc gta tta gga aac ggc tcc act 864 Gly His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Ser Thr 275 280 285 aat aaa gga atg gcg cct cag gcg aat cta gtc ttc caa tct atc atg 912 Asn Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met 290 295 300 gat agc ggt ggg gga ctt gga gga cta cct tcg aat ctg caa acc tta 960 Asp Ser Gly Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu 305 310 315 320 ttc agc caa gca tac agt gct ggt gcc aga att cat aca aac tcc tgg 1008 Phe Ser Gln Ala Tyr Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp 325 330 335 gga gca gca gtg aat ggg gct tac aca aca gat tcc aga aat gtg gat 1056 Gly Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp 340 345 350 gac tat gtg cgc aaa aat gat atg acg atc ctt ttc gct gcc ggg aat 1104 Asp Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn 355 360 365 gaa gga ccg aac ggc gga acc atc agt gca cca ggc aca gct aaa aat 1152 Glu Gly Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn 370 375 380 gca ata aca gtc gga gct acg gaa aac ctc cgc cca agc ttt ggg tct 1200 Ala Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser 385 390 395 400 tat gcg gac aat atc aac cat gtg gca cag ttc tct tca cgt gga ccg 1248 Tyr Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro 405 410 415 aca aag gat gga cgg atc aaa ccg gat gtc atg gca ccg gga acg ttc 1296 Thr Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Phe 420 425 430 ata cta tca gca aga tct tct ctt gca ccg gat tcc tcc ttc tgg gcg 1344 Ile Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala 435 440 445 aac cat gac agt aaa tat gca tac atg ggt gga acg tcc atg gct aca 1392 Asn His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr 450 455 460 ccg atc gtt gct gga aac gtg gca cag ctt cgt gag cat ttt gtg aaa 1440 Pro Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys 465 470 475 480 aac aga ggc atc aca cca aag cct tct cta tta aaa gcg gca ctg att 1488 Asn Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile 485 490 495 gcc ggt gca gct gac atc ggc ctt ggc tac ccg aac ggt aac caa gga 1536 Ala Gly Ala Ala Asp Ile Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly 500 505 510 tgg gga cga gtg aca ttg gat aaa tcc ctg aac gtt gcc tat gtg aac 1584 Trp Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn 515 520 525 gag tcc agt tct cta tcc acc agc caa aaa gcg acg tac tcg ttt act 1632 Glu Ser Ser Ser Leu Ser Thr Ser Gln Lys Ala Thr Tyr Ser Phe Thr 530 535 540 gct act gcc ggc aag cct ttg aaa atc tcc ctg gta tgg tct gat gcc 1680 Ala Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala 545 550 555 560 cct gcg agc aca act gct tcc gta acg ctt gtc aat gat ctg gac ctt 1728 Pro Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu 565 570 575 gtc att acc gct cca aat ggc aca cag tat gta gga aat gac ttt act 1776 Val Ile Thr Ala Pro Asn Gly Thr Gln Tyr Val Gly Asn Asp Phe Thr 580 585 590 tcg cca tac aat gat aac tgg gat ggc cgc aat aac gta gaa aat gta 1824 Ser Pro Tyr Asn Asp Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val 595 600 605 ttt att aat gca cca caa agc ggg acg tat aca att gaa gta cag gct 1872 Phe Ile Asn Ala Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala 610 615 620 tat aac gta ccg gtt gga cca cag aac ttc tcg ttg gca att gtg aat 1920 Tyr Asn Val Pro Val Gly Pro Gln Asn Phe Ser Leu Ala Ile Val Asn 625 630 635 640 taa 1923 8 640 PRT Bacillus sp. 8 Met Arg Lys Lys Lys Lys Val Phe Leu Ser Val Leu Ser Ala Ala Ala 1 5 10 15 Ile Leu Ser Thr Val Ala Leu Ser Asn Pro Ser Ala Gly Gly Ala Arg 20 25 30 Asn Phe Asp Leu Asp Phe Lys Gly Ile Gln Thr Thr Thr Asp Ala Lys 35 40 45 Gly Phe Ser Lys Gln Gly Gln Thr Gly Ala Ala Ala Phe Leu Val Glu 50 55 60 Ser Glu Asn Val Lys Leu Pro Lys Gly Leu Gln Lys Lys Leu Glu Thr 65 70 75 80 Val Pro Ala Asn Asn Lys Leu His Ile Ile Gln Phe Asn Gly Pro Ile 85 90 95 Leu Glu Glu Thr Lys Gln Gln Leu Glu Lys Thr Gly Ala Lys Ile Leu 100 105 110 Asp Tyr Ile Pro Asp Tyr Ala Tyr Ile Val Glu Tyr Glu Gly Asp Val 115 120 125 Lys Ser Ala Thr Ser Thr Ile Glu His Val Glu Ser Val Glu Pro Tyr 130 135 140 Leu Pro Ile Tyr Arg Ile Asp Pro Gln Leu Phe Thr Lys Gly Ala Ser 145 150 155 160 Glu Leu Val Lys Ala Val Ala Leu Asp Thr Lys Gln Lys Asn Lys Glu 165 170 175 Val Gln Leu Arg Gly Ile Glu Gln Ile Ala Gln Phe Ala Ile Ser Asn 180 185 190 Asp Val Leu Tyr Ile Thr Ala Lys Pro Glu Tyr Lys Val Met Asn Asp 195 200 205 Val Ala Arg Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly 210 215 220 Leu Tyr Gly Gln Gly Gln Ile Val Ala Val Ala Asp Thr Gly Leu Asp 225 230 235 240 Thr Gly Arg Asn Asp Ser Ser Met His Glu Ala Phe Arg Gly Lys Ile 245 250 255 Thr Ala Leu Tyr Ala Leu Gly Arg Thr Asn Asn Ala Asn Asp Thr Asn 260 265 270 Gly His Gly Thr His Val Ala Gly Ser Val Leu Gly Asn Gly Ser Thr 275 280 285 Asn Lys Gly Met Ala Pro Gln Ala Asn Leu Val Phe Gln Ser Ile Met 290 295 300 Asp Ser Gly Gly Gly Leu Gly Gly Leu Pro Ser Asn Leu Gln Thr Leu 305 310 315 320 Phe Ser Gln Ala Tyr Ser Ala Gly Ala Arg Ile His Thr Asn Ser Trp 325 330 335 Gly Ala Ala Val Asn Gly Ala Tyr Thr Thr Asp Ser Arg Asn Val Asp 340 345 350 Asp Tyr Val Arg Lys Asn Asp Met Thr Ile Leu Phe Ala Ala Gly Asn 355 360 365 Glu Gly Pro Asn Gly Gly Thr Ile Ser Ala Pro Gly Thr Ala Lys Asn 370 375 380 Ala Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly Ser 385 390 395 400 Tyr Ala Asp Asn Ile Asn His Val Ala Gln Phe Ser Ser Arg Gly Pro 405 410 415 Thr Lys Asp Gly Arg Ile Lys Pro Asp Val Met Ala Pro Gly Thr Phe 420 425 430 Ile Leu Ser Ala Arg Ser Ser Leu Ala Pro Asp Ser Ser Phe Trp Ala 435 440 445 Asn His Asp Ser Lys Tyr Ala Tyr Met Gly Gly Thr Ser Met Ala Thr 450 455 460 Pro Ile Val Ala Gly Asn Val Ala Gln Leu Arg Glu His Phe Val Lys 465 470 475 480 Asn Arg Gly Ile Thr Pro Lys Pro Ser Leu Leu Lys Ala Ala Leu Ile 485 490 495 Ala Gly Ala Ala Asp Ile Gly Leu Gly Tyr Pro Asn Gly Asn Gln Gly 500 505 510 Trp Gly Arg Val Thr Leu Asp Lys Ser Leu Asn Val Ala Tyr Val Asn 515 520 525 Glu Ser Ser Ser Leu Ser Thr Ser Gln Lys Ala Thr Tyr Ser Phe Thr 530 535 540 Ala Thr Ala Gly Lys Pro Leu Lys Ile Ser Leu Val Trp Ser Asp Ala 545 550 555 560 Pro Ala Ser Thr Thr Ala Ser Val Thr Leu Val Asn Asp Leu Asp Leu 565 570 575 Val Ile Thr Ala Pro Asn Gly Thr Gln Tyr Val Gly Asn Asp Phe Thr 580 585 590 Ser Pro Tyr Asn Asp Asn Trp Asp Gly Arg Asn Asn Val Glu Asn Val 595 600 605 Phe Ile Asn Ala Pro Gln Ser Gly Thr Tyr Thr Ile Glu Val Gln Ala 610 615 620 Tyr Asn Val Pro Val Gly Pro Gln Asn Phe Ser Leu Ala Ile Val Asn 625 630 635 640 9 20 PRT Bacillus sp. 9 Asn Asp Val Ala Arg His Ile Val Lys Ala Asp Val Ala Gln Ser Ser 1 5 10 15 Tyr Gly Leu Tyr 20 10 14 PRT Bacillus sp. 10 Gly Ile Val Lys Ala Asp Val Ala Gln Ser Ser Tyr Gly Leu 1 5 10 11 13 PRT Bacillus sp. 11 Ile Lys Pro Asp Val Met Ala Pro Gly Thr Tyr Ile Leu 1 5 10 12 20 PRT Bacillus sp. 12 Asn Ala Ile Thr Val Gly Ala Thr Glu Asn Leu Arg Pro Ser Phe Gly 1 5 10 15 Ser Tyr Ala Asp 20 13 16 PRT Bacillus sp. 13 Lys Asn Asp Met Val Ile Leu Phe Ala Ala Gly Asn Glu Gly Pro Asn 1 5 10 15 14 24 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 14 athgtnaarg cngaygtngc ncar 24 15 23 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 15 tadttyggnc trcantaccg ngg 23 16 23 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 16 athaarccng aygtnatggc ncc 23 17 24 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 17 ttrcgntadt gncanccncg ntgn 24 18 23 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 18 athacngtng gngcnacnga raa 23 19 23 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 19 ttrctrtacc antadranaa rcg 23 20 23 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 20 aaygayatgg tnatgytntt ygc 23 21 21 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 21 tcggcaactg cgacaatctg g 21 22 21 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 22 tctggaatct gtcgtgtagg c 21 23 20 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 23 aacggcggta ccatcagtgc 20 24 21 DNA Artificial/Unknown misc_feature ()..() Description of Artificial Sequence primer 24 ggaggcttgc cttccaatct g 21 

What is claimed is:
 1. An isolated alkaline protease having the sequence of SEQ ID NO: 1 or
 2. 2. The alkaline protease of claim 1, which has the sequence of SEQ ID NO:
 1. 3. The alkaline protease of claim 1, which has the sequence of SEQ ID NO:
 2. 4. An isolated nucleic acid encoding the alkaline protease of claim 1 and having the nucleic acid sequence of SEQ ID NO: 3, 5, or
 7. 5. The nucleic acid of claim 4, which has the nucleic acid sequence of SEQ ID NO:
 3. 6. The nucleic acid of claim 4, which has the nucleic acid sequence of SEQ ID NO:
 5. 7. The nucleic acid of claim 4, which has the nucleic acid sequence of SEQ ID NO:
 7. 8. A microorganism which is transformed with the nucleic acid of claim 4 and produces the alkaline protease.
 9. The microorganism of claim 8, which is a bacteria.
 10. The microorganism of claim 8, which is a yeast.
 11. The microorganism of claim 8, which is a fungus.
 12. The microorganism of claim 8, which is gram-positive.
 13. The microorganism of claim 8, which is gram-negative.
 14. The microorganism of claim 8, which is Eschericia coli.
 15. The microorganism of claim 8, which belongs to the genus Bacillus.
 16. The microorganism of claim 8, which belongs to the genus Saccharomyces.
 17. The microorganism of claim 8, which belongs to the genus Aspergillus.
 18. The microrganism of claim 8, which is selected from the group consisting of (1) Bacillus sp. KSM-KP 43, deposited under the accession number FERM BP-6532, (2) Bacillus sp. KSM-KP 1790, deposited under the accession number FERM BP-6533, and (3) Bacillus sp. KSM KP-9860, deposited under the accession number FERM BP-6534.
 19. A method of producing the microorganism of claim 15, comprising transforming a microorganism with the nucleic acid.
 20. A method of producing the alkaline protease of claim 1, comprising culturing a microorganism which produces the alkaline protease in a culture medium and then isolating the alkaline protease from the culture medium.
 21. A detergent composition comprising the alkaline protease of claim
 1. 22. The detergent composition of claim 21, which contains 0.1 to 5000 U of the alkaline protease per kg of the composition.
 23. The detergent composition of claim 22, which comprises a surfactant.
 24. The detergent composition of claim 22, which comprises 0.5 to 60 wt. % of the detergent.
 25. The detergent composition of claim 22, which contains at least one enzyme other than the alkaline protease. 